ApoLife has developed platform expression technologies for the rapid and efficient screening and production of recombinant proteins and functional human antibodies..
ApoLife’s process requires 1/3 the time for production thus lowering the cost of capital investment and has the potential of lowering the cost of final products by up to 50%. The company employs Bakers yeast, Saccharomyces cerevisiae, which has been used in manufacturing several FDA approved therapeutic products thereby providing competitive regulatory advantages over other alternate expression systems. By applying ApoLife’s proprietary "Twin Cassette" expression system, biopharma and biotechnology companies can accelerate the process of bringing the new therapies to market and help reduce the healthcare costs.
Siyu Chen, Ph.D.
In this interview, we discuss a new approach to surface-enhanced Raman spectroscopy that utilizes nano-pockets to capture target molecules, ensuring a highly sensitive way to detect chemical processes.
Dr. Yitong Dong
Dr. Yitong Dong has recently been awarded funding to study custom composite nanocrystals, which could help to create advanced quantum communication technologies. Learn more about this project in this interview.
Roey Elnathan, Ph.D.
We take a closer look at the fusion of nanotechnology and CAR-T therapy through our interview with Dr. Roey Elnathan about a new approach that harnesses the capabilities of nanoneedles to efficiently deliver genetic materials to target cells.
The Verifire™ interferometer system provides fast and reliable measurements of surface form error.
This article outlines how Unity, Oxford Instruments’ new detector for a revolutionary new imaging technique, can be used to revolutionize imaging.
Discover the compact, fast rotary table V-610 for precision testing and manufacture.